期刊文献+

PET/MRI多模态成像预测肿瘤放化疗疗效研究进展 被引量:7

Progresses of PET/MRI in predicting tumor response to chemoradiotherapy
下载PDF
导出
摘要 近年来,PET/MRI作为一种新兴的多模态成像技术正逐步应用于临床检查。不同患者或疾病对放化疗的敏感性存在差异,在治疗前及治疗初期快速、准确、无创、有效地预测肿瘤对放化疗的敏感性对制定个体化治疗方案具有重要意义。PET/MRI可同时提供肿瘤的生物学和微环境信息,在预测疗效方面具有巨大的潜力。本文对PET/MRI多模态成像预测肿瘤放化疗疗效的研究进展进行综述。 Recently,as a newly developed multi-modality imaging technology,PET/MRI is gradually applied to clinical examination.The sensitivity of chemoradiotherapy shows great differences between different patients and different diseases.It is important to predict tumor sensitivity to chemoradiotherapy easily,accurately,noninvasively and effectively before and after treatment for individual therapy.PET/MRI can provide information about tumor biology and microenvironment,and has a huge potential to predict tumor response to chemoradiotherapy.The research progresses of PET/MRI in predicting tumor response to chemoradiotherapy were reviewed in this article.
作者 张乐 孙洪赞
出处 《中国医学影像技术》 CSCD 北大核心 2017年第1期137-140,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金青年基金(81401438) 辽宁省教育厅科学研究一般项目(L2014308)
关键词 磁共振成像 体层摄影术 正电子发射型 多模态成像技术 疗效预测 Magnetic resonance imaging Tomography positron-emission Multi-modality imaging Response predic tion
  • 相关文献

参考文献2

二级参考文献32

  • 1Werner MK, Schmidt H, Schwenzer NF. MR/PET: A new chal- lenge in hybrid imaging. AJR Am J Roentgenol, 2012, 199 (2): 272-277.
  • 2Komori T, Narabayashi 1, Matsumura K, et al. 2-[Fluorine-18]- fluoro-2-deoxy-D-glucose positron emission tomography/compu- ted tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: Initial experience. Ann Nucl Med, 2007,21(4) :209 215.
  • 3Lichy MP, Asehoff P, Plathow C, et al. Tumor detection by dif- fusion weighted MRI and ADC-mapping--initial clinical experi- ences in comparison to PET-CT. Invest Radiol, 2007,42(9):605- 613.
  • 4Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo) radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys, 2007, 67 (4) :960-971.
  • 5Olsen JR, Esthappan J, Dewees T, et al. Tumor volume and subvolume concordance between FDG-PET/CT and diffusion- weighted MRI for squamous cell carcinoma of the cervix. J Magn Reson Imaging, 2013,37(2) :431-434.
  • 6Ho KC, Lin G, Wang J.[, et al. Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging, 2009,36 (2) : 200-208.
  • 7Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experi- ence with integrated whole-body PET/MR: Comparison to PET/ CT in patients with oncologie diagnoses. J Nuel Med, 2012, 53 (6) :845-855.
  • 8Choi BB, Kim SH, Kang BJ, et al. Diffusion-weighted imaging and FDG PET/CT: Predicting the prognoses with apparent diffu sion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma, World J Surg Oncol, 2012(10) :126.
  • 9Varoquaux A, Rager O, Lovblad KO, et al. Functional imaging of head and neck squamous cell carcinoma with diffusion-weigh- ted MRI and FDG PET/CT: Quantitative analysis of ADC and.SUV. Eur J Nucl Med Mol Imaging, 2013,40(6) :842-852.
  • 10Nakamura K, Joja I, Kodama J, eta plus ADC,I,, of the primary tumour is patients with cervical cancer. Eur J 2012,39(2) :283 290. Measurement of SUV a predictor of prognosis in Nucl Med Mol Imaging,.

共引文献17

同被引文献49

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部